Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 16.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | nce herein. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain |
Stammdaten
APOLLO BioWellness Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.
Unternehmen & Branche
| Name | Resonate Blends, Inc. |
|---|---|
| Ticker | KOAN |
| CIK | 0000897078 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
| SIC | 7372 · Services-Prepackaged Software |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 351.448 USD |
| Beta | 3,71 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-03-31 | 10-Q | 430,768 | -411,818 | 0.00 | 1,202,091 | -4,216,094 |
| 2024-12-31 | 10-K | 1,896,215 | -2,133,208 | -0.02 | 1,854,461 | -3,199,579 |
| 2024-12-31 | 10-Q | -2,385,208 | 1,854,461 | -3,451,579 | ||
| 2024-09-30 | 10-Q | 598,627 | -305,495 | 0.00 | 1,864,918 | -2,636,138 |
| 2024-06-30 | 10-Q | 656,228 | -708,632 | -0.01 | 1,700,015 | -2,350,643 |
| 2024-03-31 | 10-Q | 95,050 | -3,688,470 | -0.04 | 5,934,920 | -66,065 |
| 2023-12-31 | 10-Q | -1,415,979 | 992,341 | -2,135,572 | ||
| 2023-12-31 | 10-K | 16,468 | -1,415,979 | -0.02 | 992,341 | -2,135,572 |
| 2023-09-30 | 10-Q | 16,468 | -228,170 | 0.00 | 959,138 | -2,000,918 |
| 2023-06-30 | 10-Q | 6,361 | -402,310 | -0.01 | 677,551 | -2,099,146 |
| 2023-03-31 | 10-Q | 10,107 | -380,952 | -0.01 | 257,320 | -1,768,824 |
| 2022-12-31 | 10-K | 49,501 | 653,627 | 0.01 | 399,121 | -1,146,730 |
| 2022-09-30 | 10-Q | 10,429 | 62,102 | 0.00 | 641,455 | -777,675 |
| 2022-06-30 | 10-Q | 2,836 | 211,730 | 0.00 | 342,272 | -3,062,084 |
| 2022-03-31 | 10-Q | 27,652 | 490,040 | 506,048 | -3,278,319 | |
| 2021-12-31 | 10-K | 27,031 | -4,873,056 | 300,956 | -4,101,931 | |
| 2021-09-30 | 10-Q | 7,574 | 99,274 | 685,164 | -4,702,643 | |
| 2021-06-30 | 10-Q | -5,381,529 | 1,167,918 | -5,130,621 | ||
| 2021-03-31 | 10-Q | -1,058,462 | 1,776,476 | -332,300 | ||
| 2020-12-31 | 10-K | -1,941,274 | 169,024 | -996,339 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.